The European platelet rich plasma (PRP) market is poised for steady growth, with projections indicating a valuation exceeding USD 80.3 million by 2033. Driven by the increasing adoption of PRP in regenerative medicine and cosmetic treatments, the market is set to expand at a CAGR of 3.4% over the next decade, up from USD 57.5 million in 2023. https://www.fmiblog.com/2025/02/03/europes-platelet-rich-plasma-prp-market-to-surpass-usd-80-3-million-by-2033-amid-rising-demand-for-regenerative-therapies-fmi/